Clinical trials
Active, not recruiting Phase 1/2 trials in Japan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
55 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 3 |
| 2019 | 7 |
| 2020 | 6 |
| 2021 | 7 |
| 2022 | 5 |
| 2023 | 5 |
| 2024 | 11 |
| 2025 | 6 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 55 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 8 |
| Amgen | 4 |
| Novartis Pharmaceuticals | 4 |
| Eli Lilly and Company | 3 |
| Janssen Research & Development, LLC | 3 |
| Takeda | 3 |
| Bristol-Myers Squibb | 2 |
| Daiichi Sankyo | 2 |
| Institut de Recherches Internationales Servier | 2 |
| Pfizer | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 16 |
| Neoplasms | 8 |
| Colorectal Neoplasms | 6 |
| Stomach Neoplasms | 6 |
| Biliary Tract Neoplasms | 5 |
| Breast Neoplasms | 5 |
| Endometrial Neoplasms | 4 |
| Lung Neoplasms | 4 |
| Lymphoma, Large B-Cell, Diffuse | 4 |
| Recurrence | 4 |
Trials
Showing 1 to 25 of 55. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.